Alzheimer’s disease

VA Research recently published findings on Alzheimer's disease, returning Veterans to home after nursing care, and pancreatic cancer.

VA’s Office of Research and Development recently published three News Briefs highlighting research findings on a lung cancer treatment, Alzheimer's disease and maternity care.

This week, VA's Office of Research and Development published three News Briefs highlighting research advances for Veterans in caregiver training, Alzheimer's disease and toxic exposure.

Dr. Mark Logue details his research connecting PTSD and TBI with Alzheimer’s and dementia genetic risk in Veterans.

Importantly, the investigators went on to identify two FDA-approved medications that could obstruct the dangerous process. They say these drugs could suggest new directions in TBI and Alzheimer’s research and treatment.

In a secondary analysis, Kremen and his colleagues looked at brain images while controlling for the effects of general aging. They observed that the Alzheimer’s-related brain regions remained as significant predictors, suggesting that the effect was not simply due to general aging.

This scanning method could become a simple, completely non-invasive method of early Alzheimer’s detection, according to the researchers, and also has potential as a way to assess the effectiveness of treatment.

“VA has been investing in telehealth for years, so the necessary equipment and infrastructure was there,” Kraft says. “It just seemed like it was meant to be. The need was there, the resources and support were there, and the motivation was there.”

Preventing or treating Alzheimer’s a priority for VA research. One recent study focused on apathy, a common behavioral problem in those with Alzheimer’s. Doctor enthusiastic about therapy’s potential.

Alzheimer’s disease is the most common form of dementia. Dementia can affect memory and actions. Two-thirds of Americans with Alzheimer’s disease are women. And they are more than 60% of caregivers.

TRACTS, based at the VA Boston Healthcare System, is carrying out one of the most comprehensive VA studies on blast injuries on post-9-11 Veterans.

VA’s Dr. Ann McKee and Dr. Tony Wyss-Coray were recently named to TIME Magazine’s list of the 50 most influential people in health care in 2018.